Increased serum soluble programmed death ligand 1(sPD-L1) is associated with the presence of interstitial lung disease in rheumatoid arthritis: A monocentric cross-sectional study
This paper is to examine the relationship between serum soluble programmed death ligand 1(sPD-L1) levels and the development of interstitial lung disease (ILD) in patients with rheumatoid arthritis (RA).
Source: Respiratory Medicine - Category: Respiratory Medicine Authors: Xinyu Wu, Li Xu, Qi Cheng, Liuyan Nie, Songzhao Zhang, Yan Du, Jing Xue Source Type: research
More News: Arthritis | Interstitial Lung Disease | Respiratory Medicine | Rheumatoid Arthritis | Rheumatology | Study